The connection between QT dispersion and autonomic neuropathy in patients with type 2 diabetes

Experimental and Clinical Endocrinology and Diabetes

Volumn 111, Issue 6, 2003, Pages 351-357

  Takebayashi, Kohzo ^a   Sugita, R ^a   Tayama, K ^a   Aso, Y ^a   Takemura, Y ^a   Inukai, T ^a  

^a DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autonomic neuropathy; QT dispersion; Type 2 diabetes

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; AUTONOMIC NEUROPATHY; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QT INTERVAL; SYMPATHETIC NERVE; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGE OF ONSET; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LONG QT SYNDROME; MIDDLE AGED; REFERENCE VALUES; SKIN; SULFONYLUREA COMPOUNDS; TRIGLYCERIDES;

EID: 0141955050     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-42726     Document Type: Article

References (32)

1. Ali A, Malik FS, Dinshaw H, Jenkins JS, Collins T, White CJ, Ramee SR. Reduction in QT dispersion with rheolytic thrombectomy in acute myocardial infarction: evidence of electrical stability with reperfusion therapy. Catheter Cardiovasc Interv 2001; 52: 56-58
2. Arildsen H, May O, Christiansen EH, Damsgaard EM. Increased QT dispersion in patients with insulin-dependent diabetes mellitus. Int J Cardiol 1999; 71: 235-242
3. Cardoso C, Salles G, Bloch K, Deccache W, Siqueira-Filho AG. Clinical determinants of increased QT dispersion in patients with diabetes mellitus. Int J Cardiol 2001; 79: 253-262
4. Clarkson PB, Naas AA, McMahon A, MacLeod C, Struthers AD, MacDonald TM. QT dispersion in essential hypertension. QJ Med 1995; 88: 327-332
5. Cowan JC, Yusoff DK, Moore M, Amos PA, Gold AE, Bourke JP, Transuphaswadikul S, Campbell RW. Importance of lead selection in QT interval measurement. Am J Cardiol 1988; 61: 83-87
6. Davis MD. Natural evolution. In: L'Esperance FA Jr. (ed). Current Diagnosis and Management of Chorioretinal Diseases. St. Louis: CV Mosby, 1974:179-184
7. Day CP, McComb JM, Campbell RW. QT dispersion: An indication of arrythmic risk in patients with long QT interval. Br Heart J 1990; 63: 342-344
8. Day CP, McComb JM, Matthews J, Campbell RW. Reduction in QT dispersion by sotalol following myocardial infarction. Eur Heart J 1991; 12: 423-427
9. Ewing DJ, Campbell IW, Clarke BI. Heart rate changes in diabetes mellitus. Lancet 1981; 1: 183-186
10. Ewing DJ, Neison JMM. QT interval length and diabetic autonomic neuropathy. Diabetic Med 1990; 7: 23-26
11. Festa A, D'Agostino R Jr, Rantaharju P, O'Leary DH, Rewers M, Mykkanen L, Haffner SM. Is QT interval a marker of subclinical atherosclerosis in non-diabetic subjects? The Insulin Resistance Atherosclerosis Study (IRAS).
12. Fujimoto J, Hirota M, Hata M, Kondo M, Shima K. Normal reference values and prediction equations of autonomic nerve functions based on variations in R-R interval in electrocardiographs. J Japan Diab Soc 1987; 30: 167-173 (article in Japanese, abstract in English)
13. Gonin JM, Kadrofske MM, Schmaltz S, Bastyr BI, Vink AI. Corrected Q-T interval prolongation as diagnostic tool for assessment of cardiac autonomic neuropathy in diabetes mellitus. Diabetes Care 1990; 13: 68-71
14. Ichkhan K, Molnar J, Somberg J. Relation of left ventricular mass and QT dispersion in patient with systematic hypertension. Am J Cardiol 1997; 79: 508-511
15. Kirvela M, Toivonen L, Lindgern L. Cardiac repolarization interval in end-stage diabetic and nondiabetic renal disease. Clin Cardiol 1997; 20: 791-796
16. Langen KJ, Ziegler D, Weise F, Piolot R, Boy C, Hubinger A, Gries FA, Muller-Gartner HW. Evaluation of QT interval length, QT dispersion and myocardial m-iodobenzylguanidine uptake in insulin-dependent diabetic patients with and without autonomic neuropathy. Clin Sci 1997; 92: 325-333
17. Lipsitz LA. Orthostatic hypotension in the elderly. N Eng J Med 1989; 321: 952-957
18. Mayet J, Shahi M, McGrath K, Poulter NR, Sever PS, Foale RA, Thom SA. Left ventricular hypertrophy and QT dispersion in hypertension. Hypertension 1996; 28: 791-796
19. Ong JJ, Sarma JS, Venkataraman K, Levin SR, Singh BN. Circadian rhythmicity of heart rate and QTc interval in diabetic autonomic neuropathy: Implications for the mechanism of sudden death. Am Heart J 1993; 125: 744-752
20. Perkiomaki JS, Ikaheimo MJ, Pikkujamsa SM, Rantala A, Lilja M, Kesaniemi YA, Huikuri HV. Dispersion of the QT interval and autonomic modulation of heart rate in hypertensive men with and without left ventricular hypertrophy. Hypertension 1996; 28: 16-21
21. Rana BS, Band MM, Ogston S, Morris AD, Pringle SD, Struthers AD. Relation of QT interval dispersion to the number of different cardiac abnormalities in diabetes mellitus. Am J Cardiol 2002; 90: 483-487
22. Sawicki PT, Kiwitt S, Bender R, Berger M. The value of QT interval dispersion for identification of total mortality risk in non-insulin-dependent diabetes mellitus. J Intern Med 1998; 243: 49-56
23. Surawicz B. Will QT dispersion play a role in clinical decision-making? J Cardiovasc Electrophysiol 1996; 7: 777-784
24. Takebayashi K, Aso Y, Sugita R, Takemura Y, Inukai T. Clinical usefulness of corrected QT intervals in diabetic autonomic neuropathy in patients with type 2 diabetes. Diabetes Metab 2002; 28: 127-132
25. Tomiyama H, Dova N, Fu Y, Kushiro T, Hisaki R, Shinozaki Y, Kanmatsuse K, Kajiwara N, Yoshida H, Hinohara S. Left ventricular geometric patterns and QT dispersion in borderline and mild hypertension. Their evolution and regression. Am J Hypertens 1998; 11: 286-292
26. Veglio M, Chinaglia A, Borra M, Perin PC. Does abnormal QT interval prolongation reflect autonomic dysfunction in diabetic patients? QTc interval measure versus standardized tests in diabetic autonomic neuropathy. Diabetic Med 1995; 12: 302-306
27. Veglio M, Borra M, Stevens LK, Fuller JH, Perin PC and the EURODIAB IDDM Complications Study Group. The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group. Diabetologia 1999; 42: 68-75
28. Veglio M, Giunti S, Stevens LK, Fuller JH, Perin PC; EURODIAB IDDM Complications Study Group. Prevalence of Q-T interval dispersion in type 1 diabetes and its relation with cardiac ischemia: the EURODIAB IDDM Complications Study Group. Diabetes Care 2002; 25: 702-707
29. Veglio M, Bruno G, Borra M, Macchia G, Bargero G, D'Errico N, Pagano GF, Cavallo-Perin P. Prevalence of increased QT interval duration and dispersion in type 2 diabetic patients and its relationship with coronary heart disease: a population-based cohort. J Intern Med 2002; 251: 317-324
30. Wei K, Dorian P, Newman D, Langer A. Association between QT dispersion and autonomic dysfunction in patients with diabetes mellitus. J Am Coll Cardiol 1995; 26: 859-863
31. Yesilbursa D, Serdar A, Aydinlar A. Effect of successful coronary angioplasty and stent implatation on QT dispersion. Coron Artery Dis 1999; 10: 335-337
32. Yokoshiki H, Kohya T, Tomita F, Tohse N, Nakaya H, Kanno M, Kitabatake A. Restoration of action potential duration and transient outward current by regression of left ventricular hypertrophy. J Mol Cell Cardiol 1997; 29: 1331-1339